Navigation Links
Sigma-Tau Pharmaceuticals and Danisco BioActives Announce Partnership Agreement to Develop Drug Candidate for Prevention of Necrotizing Enterocolitis
Date:4/7/2009

erocolitis (NEC)

NEC is a life-threatening gastrointestinal disorder with significant morbidity and mortality primarily affecting premature infants under 1500 grams, known as very low birth weight infants. Every year, thousands of premature babies die as a result of this disease and more will suffer from abnormal neurodevelopmental outcomes. While the cause of the disease is unknown, the pathological findings of infants who died of NEC show intense mucosal inflammation, hemorrhage and transmural necrosis of the small and large intestines.

In the United States, more than 300,000 premature babies (less than 2500 grams) are born each year. Of this group, the 60,000 to 70,000 that weigh less than 1,500 grams at birth are at high risk for acquiring NEC.

About Sigma-Tau Pharmaceuticals, Inc.

Sigma-Tau Pharmaceuticals, Inc. is a U.S. based, wholly owned subsidiary of the Sigma-Tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with rare diseases. Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland.

Since 1989, the company's products have been focused on rare diseases, kidney disease, and cancer. With more than 6,000 identified rare diseases that affect approximately 25 million patients in the United States, Sigma-Tau places its considerable scientific resources behind the development and commercialization of compounds that benefit the few. The company has substantial development programs focused on transplant, cancer, inherited genetic disorders, malaria, and other areas of unmet medical need.

For more information about the company, visit www.sigmatau.com.

About Danisco

With a rich and innovative portfolio, Danisco is a world leader in food ingredients, enzymes and bio-based solutio
'/>"/>

SOURCE Sigma-Tau Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anesiva and Sigma-Tau Announce Exclusive Marketing and Distribution Agreement for Zingo(TM) in Six European Countries
2. DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease
3. Sigma-tau HealthScience Launches www.GlycoCarn.com
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market is ... from 2014 to 2019. , The global digital PCR (dPCR) and ... from 2014 to 2019. Although the mature markets such as the ... PCR (dPCR) and qPCR market the Asia-Pacific region is expected to ... The growth of the digital PCR (dPCR) and qPCR market is ...
(Date:3/5/2015)... March 05, 2015 AxoGen, Inc. ... on the peripheral nerve repair market, reported record revenue ... 31, 2014 compared to $2.98 million in the year-ago ... growth strategies. , “Our strong fourth quarter revenue ... nerve repair products which is driving increased surgeon adoption ...
(Date:3/5/2015)... March 05, 2015 Rhode Island Medical Imaging ... in a row to support the Providence College (PC) women’s ... covered the purchase of the ‘Think Pink’ uniforms, which were ... East Conference opponent DePaul University at Alumni Hall/Mullaney Gymnasium in ... our support of the PC women’s basketball’s ‘Pink Out’ event,” ...
(Date:3/5/2015)... Santa Rosa, CA (PRWEB) March 05, 2015 ... Like a SuperPro! The series aims to teach viewers ... indoor garden with hydroponics. Grow Like a SuperPro takes you ... in between. From how to clone, to how to prune ... of growing. They are offering the whole series for download ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 ... in healthcare communications and education, announced today its ... (AMP), the nation’s only medical conference designed for ... ischemia and lower limb amputation due to vascular ... family of innovative, evidence-based publications and CME activities ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3
... Pollution in State , , ... today approved two diesel truck regulations that will dramatically cut ... are the first of their kind in the United States, ... estimates that the truck regulations are expected to save 9,400 ...
... heart seen, study says , , FRIDAY, Dec. 12 (HealthDay News) ... will prove to be a valuable new weapon in the ... the drug, known as lorcaserin, resulted in substantial weight loss ... completely novel mechanism and we think it can bring very ...
... Dec. 12 For every parent who wants ... gift designed to provide higher,self-confidence, better academic results ... studies have proven that early readers have,more confidence, ... and,later in life. According to a national ...
... tumor characteristics help fine-tune treatment, study says , , FRIDAY, ... in predicting breast cancer risk, recurrence risk and response ... breast density and tumor size, a panel of experts ... teleconference Friday at the annual San Antonio Breast Cancer ...
... AURORA, Ohio, Dec. 12 PartsSource, the nation,s leading,supplier of ... the 100 fastest growing companies in Ohio by the ... third year in a row.,PartsSource placed 14th on this year,s ... award each year they were eligible. , ...
... using special program saw all injuries cut by a ... -- A good warm-up program may dramatically reduce sports ... the Norwegian School of Sport Sciences found that focusing ... cut injuries by a third among almost 1,900 teenage ...
Cached Medicine News:Health News:California Rules to Cut Diesel Truck Pollution Called Most Sweeping in U.S. 2Health News:Experimental Weight-Loss Pill Passes Early Test 2Health News:Experimental Weight-Loss Pill Passes Early Test 3Health News:VIDEO from Medialink and Your Baby Can Read: Early Literacy in Children ... Proven Path to Success 2Health News:Progress Made in Predicting Breast Cancer Risk 2Health News:Progress Made in Predicting Breast Cancer Risk 3
(Date:3/5/2015)... , March 5, 2015  ContraVir Pharmaceuticals, Inc. ... on the development and commercialization of targeted antiviral therapies, ... th Annual ROTH Conference, to be held March ... James Sapirstein , Chief Executive ... during his live presentation and will be available to ...
(Date:3/5/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... announced today that Atlanta -based Shepherd ... spinal cord injury and brain injury, has commenced enrollment ... progenitor cells) in newly injured patients with sensory and ... The Phase 1/2a trial follows the successful completion ...
(Date:3/5/2015)... and VANCOUVER, British Columbia , March ... 20B OTCQB: BMKDF) -- The ultimate goal in the ... is capable of detecting tumors before they become disruptive, ... development of such an assay has been the ... industry. Although many breakthrough diagnostics have been invented such ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4New Cancer Diagnostic Primed to Change the Industry 2New Cancer Diagnostic Primed to Change the Industry 3New Cancer Diagnostic Primed to Change the Industry 4
... designed to travel a full 120 degrees, from ... wherever you release the rotating hand grip locking ... the handle with no need to ever go ... of system was designed to mimic the natural ...
Designed for Bariatric usage. Prevents arm or leg dropout during surgical procedures. Dimensions are 16"Lx10"H come in pairs. Optional gel pad available (BD2245)...
Designed to prevent arm or legs from dropouts during surgical procedures. Dimensions are 8"H x16"L. These come as pairs. Optional gel pads(BD2245)....
... Corporation offers a quality line ... to adults. Armboard covers are ... assuring easy cleaning while reducing ... Choose from three options: Disposable ...
Medicine Products: